PRICE T ROWE ASSOCIATES INC /MD/
Position in AXSM — Axsome Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in AXSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$157,360,919
-$65,248,392 QoQ
Shares Held
642,893
-51.2% QoQ
Ownership
1.23%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#14
of 503 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. AXSM ranks #33 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in AXSM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $157,360,919 | 642,893 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $222,609,311 | 1,317,059 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $275,762,656 | 1,509,870 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $125,998,058 | 1,037,448 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $63,964,240 | 612,743 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,729,477 | 31,977 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,642,201 | 31,228 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,503,957 | 27,862 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,187,587 | 27,175 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,016,865 | 25,274 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $11,664,470 | 146,557 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $1,580,073 | 22,608 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,471,405 | 20,476 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,002,238 | 16,249 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,116,765 | 14,479 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $629,097 | 14,099 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $560,214 | 14,627 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $595,270 | 14,382 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $389,662 | 10,314 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $662,825 | 20,110 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $50,476,742 | 748,247 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $35,519,877 | 627,338 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $84,668,104 | 1,039,255 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $74,740,181 | 1,048,985 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $89,263,185 | 1,084,871 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $43,849,528 | 745,360 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||